Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir-Reference-Cited by-同舟云学术

Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir

Published:2022-06-22 Issue:13 Volume:65 Page:8686-8698
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yang Kai S.¹^ORCID,Leeuwon Sunshine Z.¹,Xu Shiqing¹^ORCID,Liu Wenshe Ray¹²³⁴^ORCID

Affiliation:

1. Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States

2. Institute of Biosciences and Technology and Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, Texas 77030, United States

3. Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, United States

4. Department of Molecular and Cellular Medicine, College of Medicine, Texas A&M University, College Station, Texas 77843, United States

Funder

Welch Foundation

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Texas A and M University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00404

Reference65 articles.

1. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis

2. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

3. A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

4. Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection

5. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

2. Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease;Bioorganic & Medicinal Chemistry Letters;2024-11

3. How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents;European Journal of Medicinal Chemistry;2024-11

4. A comprehensive study of SARS-CoV-2 mfigain protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system;PLOS Pathogens;2024-09-11

5. Nonpeptidic Irreversible Inhibitors of SARS-CoV-2 Main Protease with Potent Antiviral Activity;Journal of Medicinal Chemistry;2024-08-15